124 related articles for article (PubMed ID: 29618944)
1. Inflammation in Liver Diseases.
Feng D; Mukhopadhyay P; Qiu J; Wang H
Mediators Inflamm; 2018; 2018():3927134. PubMed ID: 29618944
[No Abstract] [Full Text] [Related]
2. Basic and Clinical Advances in Chronic Liver Inflammation.
Enomoto H; Tamori A; Yoshiji H; Seki E
Mediators Inflamm; 2016; 2016():1571457. PubMed ID: 27006527
[No Abstract] [Full Text] [Related]
3. Inflammation and liver.
Dasarathy S
JPEN J Parenter Enteral Nutr; 2008; 32(6):660-6. PubMed ID: 18974249
[No Abstract] [Full Text] [Related]
4. Mechanistic basis of hypermethioninemia.
Schweinberger BM; Wyse AT
Amino Acids; 2016 Nov; 48(11):2479-2489. PubMed ID: 27465642
[TBL] [Abstract][Full Text] [Related]
5. Current world literature.
Curr Opin Lipidol; 2011 Jun; 22(3):231-6. PubMed ID: 21562387
[No Abstract] [Full Text] [Related]
6. Editorial.
Monga SP; Jacob S
Gene Expr; 2016; 17(1):1-5. PubMed ID: 27678082
[No Abstract] [Full Text] [Related]
7. Apoptosis in liver disease.
Galle PR
J Hepatol; 1997 Aug; 27(2):405-12. PubMed ID: 9288618
[No Abstract] [Full Text] [Related]
8. Biomarkers in Pediatric Liver Disease.
Kyrana E; Fitzpatrick E; Dhawan A
Nestle Nutr Inst Workshop Ser; 2016; 84():49-58. PubMed ID: 26764473
[TBL] [Abstract][Full Text] [Related]
9. Effects of disease on expression and regulation of CYPs.
Farrell G
Mol Aspects Med; 1999; 20(1-2):55-70, 137. PubMed ID: 10575652
[No Abstract] [Full Text] [Related]
10. Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase.
Titos E; Ferré N; Lozano JJ; Horrillo R; López-Parra M; Arroyo V; Clària J
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):54-61. PubMed ID: 20227514
[TBL] [Abstract][Full Text] [Related]
11. miR-122, a paradigm for the role of microRNAs in the liver.
Girard M; Jacquemin E; Munnich A; Lyonnet S; Henrion-Caude A
J Hepatol; 2008 Apr; 48(4):648-56. PubMed ID: 18291553
[TBL] [Abstract][Full Text] [Related]
12. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
Kubota N; Kado S; Kano M; Masuoka N; Nagata Y; Kobayashi T; Miyazaki K; Ishikawa F
Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112
[TBL] [Abstract][Full Text] [Related]
13. A Single-Cell Perspective of the Mammalian Liver in Health and Disease.
Xiong X; Kuang H; Liu T; Lin JD
Hepatology; 2020 Apr; 71(4):1467-1473. PubMed ID: 31997380
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator contributes to heterogeneity of macrophages at the border of damaged site during liver repair in mice.
Kawao N; Nagai N; Tamura Y; Okada K; Yano M; Suzuki Y; Umemura K; Ueshima S; Matsuo O
Thromb Haemost; 2011 May; 105(5):892-900. PubMed ID: 21301782
[TBL] [Abstract][Full Text] [Related]
15. Hepatology over the years.
Schenker S; Bissell DM; Blei AT
Hepatology; 2006 Feb; 43(2 Suppl 1):S6-S12. PubMed ID: 16447280
[No Abstract] [Full Text] [Related]
16. Animal models of hepatotoxicity.
Bhakuni GS; Bedi O; Bariwal J; Deshmukh R; Kumar P
Inflamm Res; 2016 Jan; 65(1):13-24. PubMed ID: 26427493
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of alpha-macrofetoprotein and alpha-fetoprotein production during experimental injury.
Hudig D; Sell S; Newell L; Smuckler EA
Lab Invest; 1979 Feb; 40(2):134-9. PubMed ID: 85804
[TBL] [Abstract][Full Text] [Related]
18. Regulation of liver-specific gene expression.
Chojkier M
Prog Liver Dis; 1995; 13():37-61. PubMed ID: 9224497
[No Abstract] [Full Text] [Related]
19. Innate immune response and hepatic inflammation.
Szabo G; Mandrekar P; Dolganiuc A
Semin Liver Dis; 2007 Nov; 27(4):339-50. PubMed ID: 17979071
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases.
Gazdic M; Arsenijevic A; Markovic BS; Volarevic A; Dimova I; Djonov V; Arsenijevic N; Stojkovic M; Volarevic V
Int J Biol Sci; 2017; 13(9):1109-1117. PubMed ID: 29104502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
